- $86.45m
- $107.46m
- CNY107.90m
Annual income statement for The9, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
R2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 136 | 105 | 174 | 112 | 108 |
| Cost of Revenue | |||||
| Gross Profit | 47.8 | -47.4 | -39.1 | -1.6 | 1.81 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 419 | 817 | 489 | 189 | 496 |
| Operating Profit | -283 | -712 | -315 | -77.5 | -388 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -391 | -693 | -144 | -72.5 | -408 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -391 | -693 | -144 | -72.5 | -408 |
| Minority Interest | |||||
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -411 | -975 | 20 | -73.4 | -402 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -411 | -975 | 20 | -73.4 | -402 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.705 | -0.526 | 0.021 | -0.034 | -0.144 |